pentobarbital nembutal intravenous solution Things To Know Before You Buy
pentobarbital nembutal intravenous solution Things To Know Before You Buy
Blog Article
pentobarbital will lower the level or effect of saxagliptin by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Insignificant/Importance Unidentified.
pentobarbital will reduce the extent or influence of ibuprofen by impacting hepatic enzyme CYP2C9/10 metabolism. Minor/Significance Unknown.
pentobarbital will minimize the level or influence of clarithromycin by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Importance Unknown.
pentobarbital will lessen the extent or impact of sildenafil by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Avoid or Use Alternate Drug. Potent CYP3A4 inducers are predicted to cause substantial decreases in sildenafil plasma stages
Comment: Barbiturates may possibly maximize adverse effects, like respiratory depression, made by harmful doses of TCAs. With therapeutic doses of TCAs, barbiturates increase metabolism and reduce blood concentrations of TCAs.
pentobarbital will decrease the level or outcome of temsirolimus by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Check.
Contraindicated (1)pentobarbital will lower the extent or impact of lumefantrine by get more info impacting hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated. Coadministration with solid CYP3A4 inducers can lead to lowered serum concentrations and lack of antimalarial efficacy
Contraindicated (one)pentobarbital will minimize the level or outcome of lumacaftor/ivacaftor by affecting hepatic/intestinal enzyme CYP3A4 metabolism.
pentobarbital will minimize the extent or outcome of conjugated estrogens, vaginal by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Watch.
With therapeutic doses of TCAs, barbiturates raise metabolism and decrease blood concentrations of TCAs.
Drugs that have quantity restrictions affiliated with Each and every prescription. This restriction commonly restrictions the amount of your drug that will be covered.
pentobarbital will reduce the extent or influence of fruquintinib by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Keep away from or Use Alternate Drug. If coadministration with reasonable CYP3A4 inducers is unavoidable, carry on to administer fruquintinib at advised dosage.
pentobarbital will lower the level or impact of lefamulin by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Keep away from or Use Alternate Drug. Avoid coadministration of lefamulin with powerful or moderate CYP3A inducers unless the benefit outweighs dangers. Check for lowered efficacy.
pentobarbital will decrease the level or impact of isavuconazonium sulfate by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated.